CHD2 mutations in Lennox–Gastaut syndrome

@article{Lund2014CHD2,
  title={
 CHD2 mutations in Lennox–Gastaut syndrome},
  author={Caroline Lund and Eylert Brodtkorb and Ane-Marte {\O}ye and Oddveig R{\o}sby and Kaja K. Selmer},
  journal={Epilepsy \& Behavior},
  year={2014},
  volume={33},
  pages={18-21}
}
Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy with a heterogeneous etiology. In this study, we aimed to explore the role of CHD2 in LGS, as CHD2 mutations have been described recently in various epileptic encephalopathies. We have previously identified one patient with a large deletion affecting the CHD2 gene in a group of 22 patients with LGS or LGS-like epilepsy. In the remaining 17 patients without known etiology, Sanger sequencing revealed a de novo 1-bp duplication in the… Expand
Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families
TLDR
To identify causative mutations of Lennox-Gastaut syndrome, the whole-exome sequencing data of 17 unrelated Korean families, including patients with LGS and LGS-like epilepsy without brain abnormalities, was analyzed using the Genome Analysis Toolkit and 14 mutations in 14 genes were identified as causes. Expand
CHD2 mutations are a rare cause of generalized epilepsy with myoclonic–atonic seizures
TLDR
Chromodomain helicase DNA-binding protein 2 (CHD2) gene mutations have been reported in patients with myoclonic-atonic epilepsy (MAE) and could be responsible for a proper phenotype characterized by infantile-onset generalized epilepsy, intellectual disability, and photosensitivity, which might overlap with MAE, Lennox-Gastaut, Dravet, and Jeavons syndromes. Expand
CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures
TLDR
The phenotypic spectrum of CHD2 encephalopathy has distinctive features of myoclonic epilepsy, marked clinical photosensitivity, atonic-myoclonic-absence, and intellectual disability ranging from mild to severe. Expand
CHD2‐related epilepsy: novel mutations and new phenotypes
TLDR
The aim of this report was to refine the genotypes and phenotypes of chromodomain helicase DNA‐binding protein 2 (CHD2)‐related epilepsy and identify Q1392TfsX17, which may be a hot‐spot mutation of CHD2. Expand
CHD2-Related CNS Pathologies
TLDR
This work reviews what is known and still to be elucidated as regards to the structure and function of CHD2 and how its dysregulation leads to a highly variable range of phenotypic presentations. Expand
Lennox-Gastaut syndrome: a comprehensive review
TLDR
The seizures in Lennox-Gastaut syndrome are usually drug-resistant, and complete seizure control with resolution of intellectual and psychosocial dysfunction is often not achievable, so reduction in frequency of the most incapacitating seizures should be the major objective. Expand
Lennox‐Gastaut Syndrome: A State of the Art Review
TLDR
Clinical trials demonstrated the usefulness of different drugs, ketogenic diet, resective surgery, corpus callosotomy, and vagus nerve stimulation in the treatment of epileptic manifestations of Lennox‐Gastaut syndrome, but the outcome of LGS often remains disappointing regarding seizure control or cognitive functioning. Expand
Juvenile myoclonic epilepsy mimic associated with CHD2 gene mutation
This paper reports the electroclinical manifestations of an epilepsy syndrome associated with a chromodomain helicase DNA-binding protein 2 (CHD2) gene mutation with clinical semiology andExpand
Lennox–Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures
TLDR
The observations confirm the poor outcome of Lennox-Gastaut syndrome through adulthood, regardless of age at seizure onset, etiology, and history of previous West syndrome. Expand
Recent developments in the genetics of childhood epileptic encephalopathies: impact in clinical practice.
TLDR
The main objectives of this review paper are to present and discuss current knowledge regarding i) new genetic findings in CEEs, ii) phenotype-genotype correlations in different forms of C EEs; and, most importantly, the impact of these new findings in clinical practice. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 13 REFERENCES
SCN1A mutation screening in adult patients with Lennox–Gastaut syndrome features
TLDR
In one patient a mutation was found, which demonstrates a clinical overlap between LGS and Dravet syndrome, which emphasizes the significance of SCN1A mutations also in epileptic disorders with features of LGS, particularly in the myoclonic variant of the disorder. Expand
Copy number variants in adult patients with Lennox–Gastaut syndrome features
TLDR
A genome wide approach with identification of the genotype might shed light on the phenotype of Lennox-Gastaut syndrome and a high frequency of rare CNVs in adult patients with LGS-like epilepsy is found. Expand
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
TLDR
Target massively parallel resequencing of 19 known and 46 candidate genes for epileptic encephalopathy in 500 affected individuals (cases) to identify new genes involved and to investigate the phenotypic spectrum associated with mutations in known genes. Expand
De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.
TLDR
This study provides evidence that de novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures. Expand
De novo mutations in the classic epileptic encephalopathies
TLDR
It is shown that the de novo mutations observed are enriched in specific gene sets including genes regulated by the fragile X protein (P < 10−8), as has been reported previously for autism spectrum disorders. Expand
Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency.
TLDR
A novel chromosome microdeletion at 15q26.1 detected by oligo-array-CGH in a 6-year-old girl presenting with global development delay, epilepsy, autistic behavior and facial dysmorphisms is described, providing a further chromosome region requiring evaluation in patients presenting Angelman features. Expand
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology
TLDR
The main issues with regard to the diagnosis and treatment options available are discussed and the importance of a comprehensive approach to the assessment and management of this syndrome is highlighted. Expand
Early onset myoclonic epilepsy and 15q26 microdeletion: Observation of the first case
TLDR
The study of a 30‐month‐old girl with refractory myoclonic epilepsy associated with mental retardation, growth delay, peculiar facial appearance, and minor physical anomalies suggests that genes for seizures could be included in the 15q26.1–26.2 deletion interval. Expand
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
TLDR
The large number of de-novo variants in known intellectual disability genes is only partially attributable to known non-specific phenotypes, suggesting a strong bias in present clinical syndrome descriptions. Expand
Microdeletion of chromosome 15q26.1 in a child with intractable generalized epilepsy.
TLDR
It is proposed that a potential candidate gene or genes within the deleted region involved in the pathogenesis of some forms of generalized intractable epilepsy, previously considered to be idiopathic, may be within chromosome 15q26. Expand
...
1
2
...